| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/28/1998 | US5786373 Anticoagulants for preventing thrombosis |
| 07/28/1998 | US5786372 Heteroaryl compounds used as pharmaceuticals |
| 07/28/1998 | US5786371 Pyridine and pyridazine derivatives, processes for the production thereof and pharmaceutical agents containing these compounds |
| 07/28/1998 | US5786369 Method of inhibiting the surface expression of glycolipid receptors for bacteria |
| 07/28/1998 | US5786368 Inhibitors of glycolipids |
| 07/28/1998 | US5786366 Method and apparatus for rehydrating dry skin |
| 07/28/1998 | US5786365 Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith |
| 07/28/1998 | US5786364 Nervous system disorders; psychological disorders; drug abruse |
| 07/28/1998 | US5786363 Aqueous compositions containing ciprofloxacine, and related use |
| 07/28/1998 | US5786362 Method of treating Hormone independent cancer |
| 07/28/1998 | US5786361 Antiatherosclerosic agents |
| 07/28/1998 | US5786360 Antiallergens, central nervous system stimulants, diuretics, antihistamines, cardiotonic agents; water solubility |
| 07/28/1998 | US5786358 Inhibitors of glycinamide ribonucleotide formyl transferase |
| 07/28/1998 | US5786357 Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone |
| 07/28/1998 | US5786356 Selective β3 adrenergic agonists |
| 07/28/1998 | US5786355 4,6-diarylpyrimidine derivatives and salts thereof |
| 07/28/1998 | US5786354 Tri-substituted phenyl derivatives and processes for their preparation |
| 07/28/1998 | US5786351 Bactericides |
| 07/28/1998 | US5786350 Condensation; hydrolysis; deprotecting |
| 07/28/1998 | US5786349 Method for treating chlamydia infectious diseases by rifamycin derivative |
| 07/28/1998 | US5786348 Treating loss of bone mass or bone mineral content |
| 07/28/1998 | US5786347 Vitamin D amine and amide derivatives |
| 07/28/1998 | US5786346 Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
| 07/28/1998 | US5786345 Compositions for regulating skin wrinkles and/or skin atrophy |
| 07/28/1998 | US5786344 Camptothecin drug combinations and methods with reduced side effects |
| 07/28/1998 | US5786343 Cells for use in cosmetics and ascorbic acid with carriers |
| 07/28/1998 | US5786342 Uses of aloe products in the treatment of chronic respiratory diseases |
| 07/28/1998 | US5786339 Antibiotics |
| 07/28/1998 | US5786338 Method of treating hypercholesterolemia with a macrolide antibiotic |
| 07/28/1998 | US5786336 Granulocyte macrophage progenitor stimulants, tripeptides |
| 07/28/1998 | US5786326 Administering desferri-exochelin |
| 07/28/1998 | US5786198 Photoactivated antiviral and antitumor compositions |
| 07/28/1998 | US5786197 lep |
| 07/28/1998 | US5786187 Method for reducing neuronal degeneration associated with seizure |
| 07/28/1998 | US5786158 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 07/28/1998 | US5786157 DNA encoding human 5-HT1D receptors and uses thereof |
| 07/28/1998 | US5785995 Antiarrhythmia agents and cardiovascular disorders |
| 07/28/1998 | US5785994 Osmotic dosage form for controlled drug release |
| 07/28/1998 | US5785988 Composition for freshening nostrils and sinus cavities |
| 07/28/1998 | US5785984 Taste-modifying method and bitterness-decreasing method |
| 07/28/1998 | US5785972 Wound healing agents |
| 07/28/1998 | US5785955 Hemostatic compositions for treating soft tissue |
| 07/28/1998 | US5785952 Dry powders comprising drug and halohydrocarbon propellants for drug delivery |
| 07/28/1998 | US5785951 Use of ketorolac for treatment of oral diseases and conditions |
| 07/28/1998 | US5785950 Perfluorobis(chlorobutyl ether; medical imaging |
| 07/28/1998 | US5784992 Apparatus for injecting avian embryo muscle tissue in ovo |
| 07/28/1998 | CA2227978A1 Immune-modulation with amino acids |
| 07/28/1998 | CA2221686A1 Asp2 |
| 07/28/1998 | CA2220851A1 Cdna clone he8ch90 that encodes a novel 7-transmembrane receptor |
| 07/28/1998 | CA2141563C Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| 07/28/1998 | CA2127561C 3-azabicyclohexane compound intermediates for producing antibacterial compounds |
| 07/28/1998 | CA2105790C Nutrition for persons infected with human immunodeficiency virus |
| 07/28/1998 | CA2105072C Morphinan derivative and its pharmaceutical applications |
| 07/28/1998 | CA2082527C Use of purine derivatives for anesthesia, analgesia and in vivo organ preservation |
| 07/28/1998 | CA2079002C Ovulation-preventing agent for hormonal contraception |
| 07/24/1998 | CA2227314A1 Preparation of concealed taste preparations of antibacterially active quinolone derivatives |
| 07/24/1998 | CA2227020A1 Methods for preparing 1-deoxy paclitaxels |
| 07/23/1998 | WO1998032022A1 Growth factor-dependent diseases |
| 07/23/1998 | WO1998032017A2 Modulators of insulin receptor activity |
| 07/23/1998 | WO1998031808A1 Biological material for treating a mammal by antibody gene transfer and pharmaceutical composition containing same |
| 07/23/1998 | WO1998031796A1 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons |
| 07/23/1998 | WO1998031702A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 07/23/1998 | WO1998031699A1 Crystal form 0 of clarithromycin |
| 07/23/1998 | WO1998031686A1 Substituted 4-(6-fluoro-(1h)-indol-3-yl)-1,2,3,6-tetrahydropyridine for the treatment of cns-disorders |
| 07/23/1998 | WO1998031685A1 Purification process |
| 07/23/1998 | WO1998031680A1 1,4-dihydropyridin derivatives and their use in therapy |
| 07/23/1998 | WO1998031675A1 New triazoles as therapeutic agents for fungal infections |
| 07/23/1998 | WO1998031674A1 Phthalazinones |
| 07/23/1998 | WO1998031673A1 Terbenzimidazoles useful for medical therapy (topoisomerase inhibitors) |
| 07/23/1998 | WO1998031671A1 Pyridone derivatives, their preparation and their use as synthesis intermediates |
| 07/23/1998 | WO1998031670A1 Thrombin inhibitors |
| 07/23/1998 | WO1998031664A1 Bis-sulfonomides hydroxamic acids as mmp inhibitors |
| 07/23/1998 | WO1998031663A1 Novel modifications to 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene and processes for preparing said compound |
| 07/23/1998 | WO1998031660A1 Process for preparing indane-like compounds |
| 07/23/1998 | WO1998031654A1 Aromatic tetracyclic compounds of the retinoid type, method for preparing and use |
| 07/23/1998 | WO1998031398A1 Microparticles for delivery of nucleic acid |
| 07/23/1998 | WO1998031393A2 Polysaccharide-peptide-conjugates |
| 07/23/1998 | WO1998031381A1 Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 07/23/1998 | WO1998031380A1 Phalloidin derivatives and analogs to treat congestive heart failure |
| 07/23/1998 | WO1998031378A1 Method and substances for releasing a growth factor from endothelial cells, growth factor released in accordance with said method and use of same |
| 07/23/1998 | WO1998031374A1 Method of treating rhinoviral infections |
| 07/23/1998 | WO1998031373A1 Method of treating herpes infections |
| 07/23/1998 | WO1998031372A1 Medicament containing betasitosterol and/or phytosterol/betasitosterol mixtures |
| 07/23/1998 | WO1998031371A1 Use of δ5 androstenes in the treatment of hiv wasting syndrome |
| 07/23/1998 | WO1998031369A1 External preparations for percutaneous absorption |
| 07/23/1998 | WO1998031368A1 Dosage forms and method for ameliorating male erectile dysfunction |
| 07/23/1998 | WO1998031367A1 Method for treating acid lipase deficiency diseases with an mtp inhibitor and cholesterol lowering drugs |
| 07/23/1998 | WO1998031366A1 Method for treating atherosclerosis with an mpt inhibitor and cholesterol lowering drugs |
| 07/23/1998 | WO1998031365A1 Paroxetine compositions |
| 07/23/1998 | WO1998031364A1 3,3-disubstituted piperidines as modulators of chemokine receptor activity |
| 07/23/1998 | WO1998031362A1 Use of pramipexole in the treatment of restless legs syndrome |
| 07/23/1998 | WO1998031361A1 Pharmaceutical composition of fenofibrate with high biological availability and method for preparing same |
| 07/23/1998 | WO1998031359A1 Integrin antagonists |
| 07/23/1998 | WO1998031358A1 d-METHADONE, A NONOPIOID ANALGESIC |
| 07/23/1998 | WO1998031357A1 Use of agonists of adrenergic beta-3 receptors for preparing wound-healing medicines |
| 07/23/1998 | WO1998031356A1 Idebenone containing combination agent for treating alzheimer's disease |
| 07/23/1998 | WO1998031355A2 Pharmaceutical composition comprising n-propylnorapomorphine and cathecol-o-methyl-transferase inhibitor for treating parkinson's disease |
| 07/23/1998 | WO1998031354A2 Use of 5-ht2b agonists or potentiators in cns disorders |
| 07/23/1998 | WO1998031353A1 New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising terbutaline sulphate, a process for preparing the formulation and the use thereof |
| 07/23/1998 | WO1998031352A1 New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof |